Theranostics is a modern medical approach that combines two key steps: diagnosis and treatment. It uses a single molecule, called a vector, that targets specific diseased cells—such as cancer cells. When combined with a radioactive isotope, this molecule first helps visualize the disease through medical imaging. Then, with a different isotope, it can treat the same targeted cells precisely.

This dual approach offers many benefits: it allows for personalized treatment, better monitoring of how the disease responds, and fewer side effects. Theranostics is already showing strong results in certain cancers, such as neuroendocrine tumors and prostate cancer.

By bringing together precision, personalization, and effectiveness, theranostics is helping to shape the future of patient care.